The U.K.'s NICE recommended Altuvoct be available through the National Health Service (NHS) as a treatment for severe ...

After experiencing severe complications during past operations, columnist Jennifer Lynne is now afraid to undergo any kind of surgery.

Columnist Joe MacDonald worries about his son leaving home and moving into a dorm, where he won't be able to help him with his pain.

The treatment landscape for hemophilia with an inhibitor has changed drastically in recent years, columnist Cazandra Campos-MacDonald says.

March is Bleeding Disorders Awareness Month, and advocates are working together to call attention to the conditions.

Some women experience extremely heavy bleeding during sexual intimacy, and we need to talk about it more, says columnist.

Columnist Alliah Czarielle has been thinking a lot lately how action is the antidote to fear for her husband, who lives with hemophilia.

Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.

Pfizer said it will discontinue gene therapy Beqvez (fidanacogene elaparvovec-dzkt), an approved hemophilia B treatment.

The Loma Linda University Health (LLUH) Hemophilia Treatment Center has become the first clinic in California offering Hympavzi (marstacimab) for people with hemophilia B. “For the first time, ...